CAC
Cowen and Company’s ProQR Therapeutics PRQR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-377,776
| Closed | -$342K | – | 617 |
|
|
2022
Q1 | $342K | Sell |
377,776
-1,187,068
| -76% | -$1.07M | 0.03% | 167 |
|
|
2021
Q4 | $12.5M | Buy |
1,564,844
+1,298,183
| +487% | +$10.4M | 1.14% | 18 |
|
|
2021
Q3 | $2.23M | Hold |
266,661
| – | – | 0.11% | 85 |
|
|
2021
Q2 | $1.8M | Sell |
266,661
-19,035
| -7% | -$128K | 0.09% | 83 |
|
|
2021
Q1 | $1.89M | Hold |
285,696
| – | – | 0.13% | 80 |
|
|
2020
Q4 | $1.2M | Sell |
285,696
-12,326
| -4% | -$51.8K | 0.11% | 64 |
|
|
2020
Q3 | $1.43M | Sell |
298,022
-2,020
| -0.7% | -$9.68K | 0.23% | 64 |
|
|
2020
Q2 | $1.82M | Sell |
300,042
-54,807
| -15% | -$333K | 0.3% | 51 |
|
|
2020
Q1 | $1.95M | Buy |
354,849
+251,122
| +242% | +$1.38M | 0.45% | 45 |
|
|
2019
Q4 | $1.03M | Buy |
+103,727
| New | +$1.03M | 0.09% | 83 |
|